文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

宫颈癌螺旋断层放疗自动计划方法的开发与验证

Development and validation of an automated Tomotherapy planning method for cervical cancer.
PubMed 文献 · Radiat Oncol · 2024-07-08

本研究在30例于本中心接受螺旋断层放疗(TOMO)的宫颈癌患者中,利用RayStation计划系统脚本与Python环境开发了TOMO和容积旋转调强放疗(VMAT)的自动计划方法,并将自动TOMO(A-TOMO)与临床手动TOMO(M-TOMO)及自动VMAT(A-VMAT)计划进行比较。结果显示A-TOMO在靶区适形度和危及器官剂量降低方面优于M-TOMO,计划质量与A-VMAT相当或更优,且将计划时间显著缩短至约20分钟。

要点

  • A-TOMO靶区适形性优于M-TOMO且靶区外剂量跌落更快(P<0.01)。
  • A-TOMO降低膀胱、直肠V50Gy、V40Gy和Dmean及肠袋、股骨头、肾脏Dmean(均P<0.05)。
  • A-TOMO计划时间显著缩短至约20分钟,计划质量与A-VMAT相当或更优。

核心结论

  • 成功开发了宫颈癌A-TOMO计划方法,与M-TOMO相比改善了靶区适形性并降低了危及器官剂量。
  • A-TOMO计划质量与A-VMAT相当或更优,且显著提高了计划效率。

研究设计与样本

  • 研究纳入30例于本中心接受TOMO治疗的宫颈癌患者,利用RayStation计划系统内的脚本与Python环境开发TOMO和VMAT自动计划方法。
  • 将30例患者的临床手动TOMO(M-TOMO)计划用自动计划脚本重新优化,生成自动TOMO(A-TOMO)和自动VMAT(A-VMAT)计划,并比较A-TOMO与M-TOMO及A-VMAT计划。
  • 采用双侧Wilcoxon符号秩检验进行统计分析,P值<0.05表示有统计学意义。

主要发现

  • A-TOMO计划靶区剂量均匀性与M-TOMO相似,靶区适形性和靶区外剂量跌落更快方面有改善,差异有统计学意义(P<0.01)。
  • A-TOMO计划在降低膀胱和直肠的V50Gy、V40Gy和Dmean以及肠袋、股骨头和肾脏的Dmean方面显著优于M-TOMO计划(均P<0.05)。
  • A-TOMO计划在计划质量上表现出更好的一致性,且其质量与A-VMAT计划相当或更优。
  • A-TOMO显著缩短了治疗计划所需时间至约20分钟。

关键数值与推荐

  • A-TOMO与M-TOMO比较:靶区适形性和靶区外剂量跌落差异有统计学意义(P<0.01)。
  • A-TOMO与M-TOMO比较:膀胱和直肠的V50Gy、V40Gy和Dmean以及肠袋、股骨头和肾脏的Dmean降低均有统计学意义(均P<0.05)。
  • A-TOMO计划时间显著缩短至约20分钟。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aimed to develop an automated Tomotherapy (TOMO) planning method for cervical cancer treatment, and to validate its feasibility and effectiveness. MATERIALS AND METHODS: The study enrolled 30 cervical cancer patients treated with TOMO at our center. Utilizing scripting and Python environment within the RayStation (RaySearch Labs, Sweden) treatment planning system (TPS), we developed automated planning methods for TOMO and volumetric modulated arc therapy (VMAT) techniques. The clinical manual TOMO (M-TOMO) plans for the 30 patients were re-optimized using automated planning scripts for both TOMO and VMAT, creating automated TOMO (A-TOMO) and automated VMAT (A-VMAT) plans. We compared A-TOMO with M-TOMO and A-VMAT plans. The primary evaluated relevant dosimetric parameters and treatment plan efficiency were assessed using the two-sided Wilcoxon signed-rank test for statistical analysis, with a P-value < 0.05 indicating statistical significance. RESULTS: A-TOMO plans maintained similar target dose uniformity compared to M-TOMO plans, with improvements in target conformity and faster dose drop-off outside the target, and demonstrated significant statistical differences (P+ < 0.01). A-TOMO plans also significantly outperformed M-TOMO plans in reducing V50Gy, V40Gy and Dmean for the bladder and rectum, as well as Dmean for the bowel bag, femoral heads, and kidneys (all P+ < 0.05). Additionally, A-TOMO plans demonstrated better consistency in plan quality. Furthermore, the quality of A-TOMO plans was comparable to or superior than A-VMAT plans. In terms of efficiency, A-TOMO significantly reduced the time required for treatment planning to approximately 20 min. CONCLUSION: We have successfully developed an A-TOMO planning method for cervical cancer. Compared to M-TOMO plans, A-TOMO plans improved target conformity and reduced radiation dose to OARs. Additionally, the quality of A-TOMO plans was on par with or surpasses that of A-VMAT plans. The A-TOMO planning method significantly improved the efficiency of treatment planning.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Han F, Xue Y, Huang S, et al. Development and validation of an automated Tomotherapy planning method for cervical cancer. Radiat Oncol. 2024. PMID: 38978062. doi:10.1186/s13014-024-02482-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。